HLA-DRB1 and myeloid sarcoma: When HLA‐DRB1*15+ and HLA‐DRB1*15− MS cases were assessed separately, only HLA‐DRB1*15+ neurons demonstrated a reduction in neuron size relative to control (15+: p < 0.001; 15−: p = 0.149) (Figure 3B).